Duloxetine
Product Images NDC 60760-559

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 60760-559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dulox (Duloxetine 60760 559 30)

This is a description of a medication called Duloxetine. The medication comes in the form of delayed-release capsules, with a dosage of 60mg or 80mg. It is manufactured by Zhejiang Huahal Pharmaceutical Co. Ltd., located in China, and packaged by Managed Pharmacy Programs in Oro Valley, Arizona. The prescription should be used as directed and stored at controlled room temperature. There is also some information regarding the RX# and LOT#, but it is not clear what they are for.*

FDA Label Image

Image 1 (Image 01)

FDA Label Image

Image 2 (Image 02)

The text describes a graph that shows the proportion of patients with relapse over time. The graph displays the time from randomization to relapse (measured in days) on the X-axis and the proportion of patients on the Y-axis. The graph compares two treatments, Placebo and Duloxetine. The percentage of patients with relapse for each treatment is shown on the Y-axis ranging from 0% to 10%. The X-axis shows the time to relapse ranging from 0 to 300 days.*

FDA Label Image

Image 3 (Image 03)

FDA Label Image

Image 4 (Image 04)

FDA Label Image

Image 5 (Image 05)

FDA Label Image

Image 6 (Image 06)

The text shows a chart or graph detailing the percentage of patients who experienced improvement using different doses of Duloxetine in treating pain, compared to those who received a placebo. The chart specifically focuses on the percentage improvement in pain from a baseline and shows that the higher the dose of Duloxetine, the greater the percentage of patient improvement.*

FDA Label Image

Image 7 (Image 07)

FDA Label Image

Image 8 (Image 08)

This appears to be a graph showing the percentage of patients who improved as compared to the baseline in pain after taking either a placebo or Duloxetine 60mg once daily. The X-axis shows the percentage improvement in pain and the Y-axis shows the number of patients. However, without more context or information it is difficult to provide a further description or interpretation of this graph.*

FDA Label Image

Image 9 (Image 09)

The graph shows the percentage of patients who improved with Duloxetine medication compared to a placebo. The improvement is measured in terms of pain relief from baseline and ranges from 0% to 100%. The x-axis shows the range of pain relief percentage while the y-axis represents the frequency or number of patients. The graph suggests that patients who took Duloxetine experienced significant improvement in pain compared to the placebo.*

FDA Label Image

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.